Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines
- PMID: 36269150
- DOI: 10.1021/acsnano.2c07822
Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines
Abstract
Ionizable cationic lipid-containing lipid nanoparticles (LNPs) are the most clinically advanced non-viral gene delivery platforms, holding great potential for gene therapeutics. This is exemplified by the two COVID-19 vaccines employing mRNA-LNP technology from Pfizer/BioNTech and Moderna. Herein, we develop a chemical library of ionizable cationic lipids through a one-step chemical-biological enzyme-catalyzed esterification method, and the synthesized ionizable lipids were further prepared to be LNPs for mRNA delivery. Through orthogonal design of experiment methodology screening, the top-performing AA3-DLin LNPs show outstanding mRNA delivery efficacy and long-term storage capability. Furthermore, the AA3-DLin LNP COVID-19 vaccines encapsulating SARS-CoV-2 spike mRNAs successfully induced strong immunogenicity in a BALB/c mouse model demonstrated by the antibody titers, virus challenge, and T cell immune response studies. The developed AA3-DLin LNPs are an excellent mRNA delivery platform, and this study provides an overall perspective of the ionizable cationic lipids, from aspects of lipid design, synthesis, screening, optimization, fabrication, characterization, and application.
Keywords: COVID-19 vaccines; gene delivery; ionizable lipids; lipid nanoparticle; mRNA therapeutics.
Similar articles
-
In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression.Biomater Sci. 2022 May 31;10(11):2940-2952. doi: 10.1039/d2bm00168c. Biomater Sci. 2022. PMID: 35475455
-
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.Mol Pharm. 2022 Jul 4;19(7):2175-2182. doi: 10.1021/acs.molpharmaceut.2c00033. Epub 2022 May 31. Mol Pharm. 2022. PMID: 35642083 Free PMC article.
-
Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.Methods Mol Biol. 2024;2786:167-181. doi: 10.1007/978-1-0716-3770-8_7. Methods Mol Biol. 2024. PMID: 38814394
-
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery.J Mater Chem B. 2023 Jul 19;11(28):6527-6539. doi: 10.1039/d3tb00649b. J Mater Chem B. 2023. PMID: 37345430 Review.
-
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20. Acc Chem Res. 2021. PMID: 34668716 Review.
Cited by
-
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity.Vaccines (Basel). 2024 Feb 12;12(2):186. doi: 10.3390/vaccines12020186. Vaccines (Basel). 2024. PMID: 38400169 Free PMC article. Review.
-
Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy.J Nanobiotechnology. 2024 Aug 20;22(1):495. doi: 10.1186/s12951-024-02776-y. J Nanobiotechnology. 2024. PMID: 39164753 Free PMC article.
-
Leveraging high-throughput screening technologies in targeted mRNA delivery.Mater Today Bio. 2024 May 29;26:101101. doi: 10.1016/j.mtbio.2024.101101. eCollection 2024 Jun. Mater Today Bio. 2024. PMID: 38883419 Free PMC article. Review.
-
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.Life (Basel). 2023 Mar 29;13(4):903. doi: 10.3390/life13040903. Life (Basel). 2023. PMID: 37109432 Free PMC article. Review.
-
mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy.Nat Commun. 2023 Jul 15;14(1):4223. doi: 10.1038/s41467-023-39938-9. Nat Commun. 2023. PMID: 37454146 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous